Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples